“How to manage antithrombotic treatments in thrombocytopenic patients with cancer. Comments on the European Haematology Association guidelines”, Bleeding Thromb Vascul Biol, vol. 2, no. 1, Jan. 2023, doi: 10.4081/btvb.2023.60.